Enter the first few characters of Company and click 'Go'
Anuh Pharma Ltd. Company History and Annual Growth Details
1961 - Anuh Pharma Ltd was incorporated.
- In early January, the promoters sold off nearly 14.9% of their stake in the company.
-Anuh Pharma has given the Bonus in the Ratio of 1:1
-Company has splits its Face value of Shares from Rs 10 to Rs 5
-Anuh Pharma has given the Bonus in the Ratio of 2:1
-Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00.
-Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory.
-Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00.
-Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00.
-Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate.
-Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share.
-The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1.
-Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France.